| Identification | Back Directory | [Name]
N-(4-((3R,4R,5S)-3-aMino-4-hydroxy-5-Methylpiperidin-1-yl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinaMide | [CAS]
1210417-75-6 | [Synonyms]
N-(4-((3R,4R,5S)-3-aMino-4-hydroxy-5-Methylpiperidin-1-yl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinaMide
N-[4-[(3R,4R,5S)-3-amino-4-hydroxy-5-methylpiperidin-1-yl]pyridin-3-yl]-6-(2,6-difluorophenyl)-5-fluoropyridine-2-carboxamide
2-Pyridinecarboxamide, N-[4-[(3R,4R,5S)-3-amino-4-hydroxy-5-methyl-1-piperidinyl]-3-pyridinyl]-6-(2,6-difluorophenyl)-5-fluoro- | [Molecular Formula]
C23H22F3N5O2 | [MOL File]
1210417-75-6.mol | [Molecular Weight]
457.45 |
| Hazard Information | Back Directory | [Uses]
LGB321 is an inhibitor of PIM2-dependent multiple myeloma cell lines, effectively inhibiting proliferation and key signaling pathways such as mTOR-C1 and phosphorylation of BAD[1]. | [References]
[1] Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic Cancers |
|
| Company Name: |
SPIRO PHARMA
|
| Telephone: |
|
| Website: |
www.spiropharma.com.cn |
|